Natural Capsules Quarterly Results for Trading Insights
NATCAPSUQ • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-7 Cr
QSept 2025
Natural Capsules Quarterly Results Key Highlights
- Revenue of ₹46 Cr in Sept 2025 (+2.2% vs Mar 2025, +12.2% vs Sept 2024)
- Net Profit of ₹-7 Cr in Sept 2025 (-800.0% vs Mar 2025, -600.0% vs Sept 2024)
- EBITDA of ₹-1 Cr in Sept 2025 (-120.0% vs Mar 2025)
- Operating Margin of -2.0% in Sept 2025 (-12.0pp vs Mar 2025)
- Earnings Per Share of ₹-6.76 in Sept 2025 (-5300.0% vs Mar 2025)
Natural Capsules Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 46 | 45 | 46 | 41 | 41 | 2.2% | 12.2% |
| Net Profit (₹ Cr) | -7 | 1 | -6 | -1 | 1 | - | - |
| EBITDA (₹ Cr) | -1 | 5 | 1 | 5 | 5 | - | - |
| EPS (₹) | -6.76 | 0.13 | -5.40 | -0.60 | 1.31 | - | - |
| Operating Margin (%) | -2.0% | 10.0% | 1.0% | 11.0% | 10.0% | - | - |
Natural Capsules Share Price Trend Around Quarterly Results
Visualize Natural Capsules's 1-year price movement across quarterly results — ideal for logging trades in Natural Capsules share price
chart using Tickjournal. All values in ₹.
Related Pages for Natural Capsules
Additional stock information and data for NATCAPSUQ
Revenue Trend (₹ Cr)
Sept 2024
41
Jun 2025
46
Mar 2025
45
Sept 2025
46
Net Profit Trend (₹ Cr)
Sept 2024
-1
Jun 2025
-6
Mar 2025
1
Sept 2025
-7
Operating Margin Trend (%)
Sept 2024
11.0%
Jun 2025
1.0%
Mar 2025
10.0%
Sept 2025
-2.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Natural Capsules quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.7 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6600.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4026.4 | 3,219 | 591 | +11.3% | - | 18.4% | 229.6 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1460.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1206.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores